Cardiac computed tomography-derived extracellular volume fraction in the identification of cardiotoxicity: Another emerging imaging option.
作者信息
Schindler Thomas H, Sharma Vijay, Bhandiwad Anita
机构信息
Mallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Cardiovascular Division, John T. Milliken Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
出版信息
Int J Cardiol Heart Vasc. 2021 Jun 4;34:100806. doi: 10.1016/j.ijcha.2021.100806. eCollection 2021 Jun.
Abstract
摘要
相似文献
1
Cardiac computed tomography-derived extracellular volume fraction in the identification of cardiotoxicity: Another emerging imaging option.
Int J Cardiol Heart Vasc. 2021 Jun 4;34:100806. doi: 10.1016/j.ijcha.2021.100806. eCollection 2021 Jun.
2
Myocardial extracellular volume fraction with spectral detector computed tomography for risk stratification in non-ischemic heart failure.
Radiol Med. 2025 Apr 30. doi: 10.1007/s11547-025-02002-1.
3
MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review.
J Nucl Cardiol. 2022 Oct;29(5):2274-2291. doi: 10.1007/s12350-021-02610-0. Epub 2021 Jul 6.
4
Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cochrane Database Syst Rev. 2011 Sep 7(9):CD008011. doi: 10.1002/14651858.CD008011.pub2.
5
Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cochrane Database Syst Rev. 2016 Aug 23;2016(8):CD008011. doi: 10.1002/14651858.CD008011.pub3.
6
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base.
Malar J. 2009 Dec 10;8:289. doi: 10.1186/1475-2875-8-289.
7
Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis.
Int J Clin Pharm. 2021 Feb;43(1):25-34. doi: 10.1007/s11096-020-01146-6. Epub 2020 Sep 10.
8
The Joint Role of Serum Markers of Congestion or Myocardial Necrosis And Speckle Tracking Echocardiography in The Detection of Early Subtle Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer.
Kardiologiia. 2025 Jul 7;65(6):34-43. doi: 10.18087/cardio.2025.6.n2933.
9
Photon-counting CT-derived extracellular volume in acute myocarditis: Comparison with cardiac MRI.
Diagn Interv Imaging. 2025 Jul-Aug;106(7-8):255-263. doi: 10.1016/j.diii.2025.03.001. Epub 2025 Mar 18.
10
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2.
引用本文的文献
1
CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens.
Cancers (Basel). 2024 Jan 29;16(3):563. doi: 10.3390/cancers16030563.
2
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab.
J Pers Med. 2023 Jan 22;13(2):199. doi: 10.3390/jpm13020199.
3
Cardiac computed tomography-derived myocardial tissue characterization after anthracycline treatment.
ESC Heart Fail. 2022 Jun;9(3):1792-1800. doi: 10.1002/ehf2.13867. Epub 2022 Mar 15.
本文引用的文献
1
Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity.
Int J Cardiol Heart Vasc. 2021 May 18;34:100797. doi: 10.1016/j.ijcha.2021.100797. eCollection 2021 Jun.
2
Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.
Circ Res. 2021 May 14;128(10):1576-1593. doi: 10.1161/CIRCRESAHA.121.318223. Epub 2021 May 13.
3
Role of cardiovascular magnetic resonance imaging in cardio-oncology.
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):383-396. doi: 10.1093/ehjci/jeaa345.
4
The effect of prophylactic carvedilol on subclinical left ventricular dysfunction after 1 cycle FAC chemotherapy in breast cancer patients.
Int J Cardiol Heart Vasc. 2020 Jul 3;29:100575. doi: 10.1016/j.ijcha.2020.100575. eCollection 2020 Aug.
5
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
Eur J Heart Fail. 2020 Sep;22(9):1504-1524. doi: 10.1002/ejhf.1957. Epub 2020 Aug 21.
6
Low-dose oral cyclophosphamide therapy reduces atherosclerosis progression by decreasing inflammatory cells in a murine model of atherosclerosis.
Int J Cardiol Heart Vasc. 2020 May 10;28:100529. doi: 10.1016/j.ijcha.2020.100529. eCollection 2020 Jun.
7
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity.
Curr Cardiol Rep. 2020 Jun 19;22(8):62. doi: 10.1007/s11886-020-01315-z.
8
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
Eur J Heart Fail. 2020 Nov;22(11):1945-1960. doi: 10.1002/ejhf.1920. Epub 2020 Aug 6.
9
Cardiotoxicity from immune checkpoint inhibitors.
Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. eCollection 2019 Dec.
10
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases.
Lancet. 2019 Sep 21;394(10203):1041-1054. doi: 10.1016/S0140-6736(19)31674-5. Epub 2019 Aug 20.
Zotero 插件